MedPath
FDA Approval

Cystadane

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 9, 2015
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Betaine(6 g in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments2

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Rare Disease Therapeutics, Inc.

Rare Disease Therapeutics, Inc.

Rare Disease Therapeutics, Inc.

966133100

Ropack Pharmaceutical

Rare Disease Therapeutics, Inc.

Rare Disease Therapeutics, Inc.

209989631

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cystadane

Product Details

NDC Product Code
66621-4000
Application Number
NDA020576
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
October 10, 2010
BetaineActive
Code: 3SCV180C9WClass: ACTIBQuantity: 6 g in 1 1
© Copyright 2025. All Rights Reserved by MedPath